Orthocell Ltd.

Orthocell Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.06
Market Cap
AUD74.38 M
Shares Outstanding
152.97 M
Public Float
-

Profile

Address
Building 191
Murdoch Western Australia (WA) 6150
Australia
Employees -
Website http://www.orthocell.com.au
Updated 07/08/2019
Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which derives collagen medical device for soft tissue repair; and Antologous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

Financials

View All
Created with Highcharts 5.0.14Orthocell Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.2 1822 1823 7423 7423 7843 7844 1774 1775 7575 7572014201520162017201801k2k3k4k5k6k7k
Created with Highcharts 5.0.14Orthocell Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.6916917907906666665295296196192014201520162017201802004006008001000

Stewart James Washer
Executive Chairman
Paul Anderson
Chief Executive Officer, Executive Director & MD